Table 1.
Patient characteristics of all notified COVID-19 cases and of hospitalized cases, excluding health care workers, the Netherlands, 28 February–1 June 2020, n = 29539
| All cases (N = 29,539) | Hospitalised cases (N = 11,227) | |||||
|---|---|---|---|---|---|---|
| Male | Female | p | Male | Female | p | |
| n | 14,627 | 14,912 | 7057 | 4170 | ||
| Age (median [IQR]) | 71.00 [56.00, 81.00] | 78.00 [60.00, 87.00] | < 0.001 | 69.00 [58.00, 77.00] | 71.00 [59.00, 79.00] | < 0.001 |
| Age (%) | ||||||
| 0–54 | 3213 (22.0) | 2920 (19.6) | < 0.001 | 1271 (18.0) | 793 (19.0) | < 0.001 |
| 55–69 | 3814 (26.1) | 2432 (16.3) | 2359 (33.4) | 1167 (28.0) | ||
| 70–84 | 5274 (36.1) | 4770 (32.0) | 2838 (40.2) | 1702 (40.8) | ||
| 85 + | 2326 (15.9) | 4790 (32.1) | 589 (8.3) | 508 (12.2) | ||
| Nursing home resident | 2745 (18.8) | 5582 (37.4) | < 0.001 | 214 (3.0) | 254 (6.1) | < 0.001 |
| Hospital admission | 7057 (48.2) | 4170 (28.0) | < 0.001 | – | – | – |
| Comorbidity data available (n)* | 7395 | 5949 | 4811 | 2716 | ||
| Any comorbidity | 5530 (74.8) | 4696 (78.9) | < 0.001 | 3565 (74.1) | 2149 (79.4) | < 0.001 |
| Cardiovascular disease or hypertension | 2958 (40.0) | 2308 (38.8) | 0.163 | 2013 (41.8) | 1026 (37.2) | < 0.001 |
| Diabetes | 1293 (17.5) | 1006 (16.9) | 0.395 | 890 (18.5) | 504 (18.3) | 0.843 |
| Liver disease | 63 (0.9) | 43 (0.7) | 0.461 | 49 (1.0) | 18 (0.7) | 0.132 |
| Chronic neuromuscular disease | 606 (8.2) | 617 (10.4) | < 0.001 | 234 (4.9) | 144 (5.2) | 0.523 |
| Immunodeficiency | 90 (1.2) | 61 (1.0) | 0.338 | 61 (1.3) | 33 (1.2) | 0.874 |
| Renal impairment | 478 (6.5) | 428 (7.2) | 0.102 | 293 (6.1) | 203 (7.4) | 0.035 |
| Chronic lung disease | 1335 (18.1) | 1145 (19.2) | 0.082 | 914 (19.0) | 635 (23.0) | < 0.001 |
| Malignancy | 628 (8.5) | 486 (8.2) | 0.523 | 405 (8.4) | 252 (9.1) | 0.300 |
| Other underlying disease | 1099 (14.9) | 1103 (18.5) | < 0.001 | 677 (14.1) | 545 (19.8) | < 0.001 |
*In some cases more than one comorbidity has been reported